Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Transformation and Oncogenesis

Adenovirus Protein E4orf4 Induces Premature APCCdc20 Activation in Saccharomyces cerevisiae by a Protein Phosphatase 2A-Dependent Mechanism

Melissa Z. Mui, Diana E. Roopchand, Matthew S. Gentry, Richard L. Hallberg, Jackie Vogel, Philip E. Branton
Melissa Z. Mui
1Departments of Biochemistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diana E. Roopchand
1Departments of Biochemistry
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthew S. Gentry
2Department of Molecular and Cellular Biochemistry and Center for Structural Biology, University of Kentucky College of Medicine, 741 S, Limestone, BBSRB, B177, Lexington, Kentucky 40536-0509
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Hallberg
3Department of Biology, Syracuse University, Syracuse, New York 13244
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jackie Vogel
4Department of Biology
5DBRI, McGill University, Bellini Pavilion, Room 2691B1, McGill Life Sciences Complex, 3649 Promenade Sir William Osler, Montreal, Quebec H3G 0B1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philip E. Branton
1Departments of Biochemistry
6Oncology
7the Goodman Cancer Centre, McGill University, McIntyre Medical Building, Room 822, 3655 Promenade Sir William Osler, Montreal, Quebec H3G 1Y6, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: philip.branton@mcgill.ca
DOI: 10.1128/JVI.02434-09
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Protein phosphatase 2A (PP2A) has been implicated in cell cycle progression and mitosis; however, the complexity of PP2A regulation via multiple B subunits makes its functional characterization a significant challenge. The human adenovirus protein E4orf4 has been found to induce both high Cdk1 activity and the accumulation of cells in G2/M in both mammalian and yeast cells, effects which are largely dependent on the B55/Cdc55 regulatory subunit of PP2A. Thus, E4orf4 represents a unique means by which the function of a specific form of PP2A can be delineated in vivo. In Saccharomyces cerevisiae, only two PP2A regulatory subunits exist, Cdc55 and Rts1. Here, we show that E4orf4-induced toxicity depends on a functional interaction with Cdc55. E4orf4 expression correlates with the inappropriate reduction of Pds1 and Scc1 in S-phase-arrested cells. The unscheduled loss of these proteins suggests the involvement of PP2ACdc55 in the regulation of the Cdc20 form of the anaphase-promoting complex (APC). Contrastingly, activity of the Hct1 form of the APC is not induced by E4orf4, as demonstrated by the observed stability of its substrates. We propose that E4orf4, being a Cdc55-specific inhibitor of PP2A, demonstrates the role of PP2ACdc55 in regulating APCCdc20 activity.

Protein phosphatase 2A (PP2A) represents a major class of serine/threonine phosphatases that is evolutionally conserved across eukaryotes and plays a regulatory role in numerous cellular processes, including signal transduction, cell morphology, and cell cycle control (12, 15, 26, 43). The diversity of PP2A functions is due primarily to the existence of several PP2A holoenzyme variants. PP2A generally exists as a heterotrimer, composed of a catalytic C subunit, a structural A subunit, and a crucial regulatory B subunit that not only confers substrate specificity to the enzyme but also directs its cellular localization (13). In mammalian cells, there exist at least 18 known B regulatory subunit isoforms categorized into three classes (B, B′, and B′′) and a related fourth class (sometimes referred to as B′′′). These classes share very little or no homology, despite their common abilities to bind overlapping sites within the A subunit (12). The situation is simpler in yeast, in which the catalytic C subunit is encoded redundantly by two duplicated genes, PPH21 and PPH22; a single A subunit is encoded by TPD3; and only two B-type subunits exist, encoded by CDC55 (corresponding to mammalian B/B55 subunits) and RTS1 (corresponding to the B′/B56 family) (51). Nevertheless, it is difficult to determine what particular form of PP2A actually functions in specific PP2A-regulated processes in all eukaryotic cells. PP2A has previously been implicated in the control of mitotic events in yeast and higher eukaryotes that are essential for cell survival (12, 15); however, the precise role of PP2A regarding mitotic progression and cell cycle regulation has yet to be fully defined, especially with regard to the specific form of PP2A that is involved.

The E4orf4 (early region 4 open reading frame 4) protein of human adenoviruses is a 114-residue polypeptide containing an arginine-rich nuclear/nucleolar targeting sequence (27) shown previously to induce the p53-independent death of human cancer cells when expressed alone in the absence of other viral proteins (1, 19-23, 36-38). More importantly, E4orf4 protein was shown to bind to the B55α regulatory subunit of PP2A (1, 22, 37, 38), and analysis of a series of E4orf4 mutants revealed that functional interaction between E4orf4 and B55α correlates with tumor cell killing (22, 37). We have shown recently that E4orf4 protein interacts only with members of the B/B55 class of regulatory subunits in mammalian cells (20), and it is widely accepted that this interaction is important in eliciting toxicity in mammalian cells. Our group and others have also shown that E4orf4 is lethal when expressed in the budding yeast Saccharomyces cerevisiae (1, 17, 32). In yeast, E4orf4 protein binds to Cdc55, and the interaction between E4orf4 and the A and C subunits of the PP2A holoenzyme is entirely dependent on its binding to Cdc55 (32). The majority of E4orf4-induced toxicity is relieved in cdc55Δ mutant strains, suggesting that the PP2ACdc55 complex is involved in E4orf4-induced cell death (17, 32). While the specific mechanism by which E4orf4 reduces viability in yeast is unclear, PP2ACdc55 is likely to play a significant role. PP2A is known to play a role in the regulation of mitotic events, and we have observed previously that E4orf4 expression triggers mitotic arrest accompanied by elevated levels of Cdk1/Clb2-Cdc28 in both mammalian cells (20, 21) and yeast (32). Thus, it is reasonable to speculate that E4orf4 toxicity is elicited through the perturbation of signaling pathways critical for orderly progression through mitosis.

Mitosis is a tightly regulated process, and the switch-like transition between metaphase and anaphase depends on multiple control inputs, one of which is the precise timing of the activation of the anaphase-promoting complex (APC) or cyclosome. The APC is a multisubunit E3 ubiquitin ligase which degrades a number of proteins, including the cyclins that drive the metaphase activity of Cdk1, and securin (Pds1), a protein which inhibits the protease separase/Esp1. The coordinated activation of two forms of APC is dependent on its interaction with cofactors Cdc20 and Hct1 (28, 29, 44). Activation of the APC by Cdc20 is achieved through many regulatory pathways, one of which is the rise in Clb2-Cdc28/Cdk1 activity as cells enter mitosis. Thus, one mechanism controlling the timing of mitotic events is the balance between the inhibitory phosphorylation of Cdc28 on residue Y19 by the Wee1 ortholog Swe1 and the removal of the Y19 phosphate group by the Mih1 phosphatase, which activates Cdk1 (24). When Cdk1 activity rises, APC core subunits themselves become phosphorylated (18, 33). The completion of sister chromatid biorientation promotes the binding of Cdc20 to the APC (49). Active APCCdc20, in turn, degrades securin/Pds1 (5) and allows separase/Esp1 to cleave the cohesin Scc1. These events are critical for sister chromatid separation and the onset of anaphase (4, 5, 41, 42). Premature activation of the APC would be deleterious, as this would compromise the accurate segregation of chromosomes.

High levels of Clb2-Cdc28/Cdk1 inhibit the activation of the second form of the APC, APCHct1, through phosphorylation of the Hct1 cofactor itself (14). Thus, failure to degrade the B-type cyclins, as well as Cdc20, prevent anaphase exit (50). The dampening of Clb2-Cdc28/Cdk1 activity is achieved through the initial degradation of Clb2, which is mediated by APCCdc20. This allows partial APCHct1 formation, which then becomes fully activated as Cdc20 is progressively degraded (48). Formation of an active APCHct1 together with the actions of the Cdc-fourteen early release (FEAR) and mitotic exit network (MEN) pathways, allows for proper mitotic exit and subsequent cytokinesis (6). Interestingly, Cdc55 has been implicated in the regulation of APCCdc20 and has been reported to play a role in mitotic exit, acting at the level of both the FEAR and MEN pathways (30, 31, 45-47).

We have shown recently with mammalian cells that binding of E4orf4 reduces the activity of B55α-containing PP2A holoenzymes when measured in vitro using purified complexes and substrates and that, in vivo, certain putative targets of this form of PP2A, including 4EBP-1 and p70S6K, are hyperphosphorylated following E4orf4 expression (20). In addition, the PP2A inhibitors okadaic acid and I-PP2A were found to enhance E4orf4 killing, which was also shown to be enhanced with increasing concentrations of E4orf4 protein. Thus, we have postulated that the toxic effects of E4orf4 could be elicited when a sufficient proportion of the B55/Cdc55-containing PP2A holoenzyme population is inhibited to prevent the dephosphorylation of key substrates (20).

We propose that E4orf4 may provide a unique tool for specific interrogation of the role that PP2ACdc55 plays in the regulation of mitotic events and for identification of PP2ACdc55 substrates. In the present study, we hypothesized that E4orf4, through its interaction with Cdc55, may uncouple PP2ACdc55 regulation of mitotic events. This uncoupling would result in the unscheduled activation of APCCdc20, leading to degradation of specific APC substrates and mitotic defects. To understand the mechanism by which E4orf4-expressing cells develop these defects, which when left uncorrected ultimately culminates in decreased viability of cells, we examined the activity of APCCdc20 and APCHct1in vivo to determine precisely the transition point affected by E4orf4 expression. We show here that, in a PP2ACdc55-dependent manner, E4orf4 induces the premature activation of APCCdc20 but not APCHct1, suggesting that PP2ACdc55 plays an important regulatory role in anaphase exit.

MATERIALS AND METHODS

Strains, plasmids, and media.The yeast strains used in this study (Table 1) are all derivatives of W303. Wild-type hemagglutinin-tagged E4orf4 (HA-E4orf4) and HA-E4orf4 point mutants were subcloned from mammalian expression vectors into either the p424GAL1 or p425GAL1 (ATCC) DNA vector under the control of the GAL1 promoter. The same was done for FLAG-tagged E4orf4. HA-E4orf4 was also subcloned into the pYES2 (Invitrogen) DNA vector by the same method. The Clb2-HA3 plasmid (GAL1pr, CEN, and URA) was obtained from Brenda J. Andrews (University of Toronto). Yeast transformations were performed using the one-step method of Chen et al. (3). Transformants were selected on synthetic complete medium containing 2% glucose and the appropriate auxotrophic supplements.

View this table:
  • View inline
  • View popup
TABLE 1.

Yeast strains

Cell synchronization experiments and FACS analysis.Yeast strains transformed with galactose-inducible control, FLAG-E4orf4, or HA-E4orf4 DNA plasmids were grown in glucose-containing synthetic complete medium overnight and then rediluted into fresh medium and allowed to incubate for 2 h. Cells were then transferred to medium containing 2% raffinose, 0.2% glucose, and 0.2 M hydroxyurea (HU) (Sigma) for 5 h to synchronize cells in S phase. After a 5-h synchronization period (T = 0 h), cells were resuspended in fresh medium containing 2% raffinose, 2% galactose, and 0.2 M HU to maintain the S-phase arrest during induction of E4orf4 expression. Cells were harvested after 3 or 4 h of galactose induction. Cell samples were processed for Western blotting (described below) as well as fluorescence-activated cell sorting (FACS) analysis following the method outlined by Dien et al. (7). Propidium iodide-stained cells were acquired on a FACScan instrument, using Cell Quest software. Cell cycle histograms were created using FCS Express V3.

Western blot analysis.Whole-cell extracts (WCEs) were prepared by resuspending cells in yeast lysis buffer (25 mM Tris-Cl, pH 7.4, containing 125 mM NaCl, 2.5 mM EDTA, 1% Triton X-100, and protease inhibitors) and vortexing them with acid-washed glass beads (Sigma). Protein amounts were quantified by Bio-Rad protein assay reagent, and 20 to 50 μg of total protein per sample was resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE). Separated proteins were transferred to polyvinylidene difluoride (PVDF) membranes (Millipore) and immunoblotted with the indicated antibodies. Anti-HA (HA.11; Covance), anti-(M2) FLAG (Sigma-Aldrich), and anti-Myc (9E10; Covance) antibodies were all used at 1:1,000 dilutions. Rabbit polyclonal anti-Cdc28 (a gift from Raymond J. Deshaies, California Institute of Technology) was used at a 1:2,000 dilution as a loading control. Membranes were incubated with secondary antibody linked to horseradish peroxidase (Jackson ImmunoResearch) at a 1:10,000 dilution, and enhanced chemiluminescence (ECL) detection (PerkinElmer) followed.

Coimmunoprecipitation assay.Yeast strains expressing HA3-Cdc55 or Rts1-HA3 (9, 39) were transformed with either vector control plasmid DNA or plasmid DNA encoding FLAG-E4orf4. Cells were grown overnight in 2% glucose-containing synthetic complete medium, transferred to 2% raffinose medium for 2 h, and finally resuspended in 2% galactose-2% raffinose medium for 6 h to induce E4orf4 expression. Cells were lysed with yeast lysis buffer (as described above), and 20 μg of WCE was used to detect protein expression by Western blotting. For each sample, 1 mg of WCE was precleared with protein G agarose beads (50% slurry) (Upstate) for 1 h, and the precleared lysates were subjected to immunoprecipitation with anti-HA antibody for 2 h at 4°C. Immunoprecipitates were washed five times with lysis buffer, heated in sample buffer for 5 min, and subjected to SDS-PAGE, PVDF transfer, and Western blotting with appropriate antibodies.

Kinase immunoprecipitation assay.Yeast strains transformed with control vector DNA or plasmid DNA expressing Clb2-HA3 under the GAL1 promoter were grown in 2% glucose-containing medium overnight, transferred to 2% raffinose for 2 h, and finally resuspended in fresh medium containing 2% raffinose and 2% galactose for 4 h to induce Clb2 expression. Cells were collected and lysed as described above. A total of 20 μg of WCE was used to detect Clb2 expression by immunoblotting. A total of 400 μg of WCE was immunoprecipitated with 0.5 μg of rabbit polyclonal Clb2 antibody (Santa Cruz) and 12 μl of protein A agarose beads (50% slurry) (Upstate) after 1 h of preclearing with protein A agarose beads. Immunoprecipitates were washed four times in lysis buffer and two times in kinase assay buffer (50 mM HEPES, pH 7.5, 1 mM EGTA, 2 mM MgCl2, 1 mM dithiothreitol [DTT]). Immunoprecipitates were then incubated for 30 min at 30°C in 20 μl of reaction mix containing kinase assay buffer, 10 μg histone H1 (Sigma), and 10 μCi [γ32P]ATP (specific activity, 6,000 Ci/mmol). Kinase reactions were stopped by the addition of 10 μl of 4× sample buffer and the heating of samples at 100°C for 5 min. Proteins were separated by SDS-PAGE using 15% polyacrylamide gels and then transferred to PVDF membranes. The level of γ32P-labeled H1 was determined by autoradiography.

Cell growth and colony survival assays.Spotting cell growth assays were performed as previously described (32). Briefly, cells were grown overnight in 2% glucose-containing synthetic complete medium and then resuspended in 2% raffinose medium for 2 h. Approximately equal numbers of cells were serially diluted, and equal volumes spotted onto 2% glucose-containing control plates and 2% raffinose-2% galactose plates and incubated at 30°C for 2 days, after which pictures were taken. The colony survival assays performed were done in a similar fashion. Cells grown overnight in 2% glucose-containing synthetic complete medium were first resuspended in 2% raffinose medium for 2 h (T = 0 h) and then switched to 2% raffinose-2% galactose medium to induce E4orf4 expression for 3, 6, and 9 h (T = 3 h, 6 h, and 9 h). Immediately, approximately 300 cells were plated onto glucose-containing plates (3 replica plates) and incubated at 30°C for 2 days, after which colony numbers were counted.

Microscopy.Yeast strains carrying green fluorescent protein (GFP)-tagged Cdc55 or Rts1 (9) were transformed with control vector DNA or pYES2HA-E4orf4 plasmid. Cells were grown in 2% glucose-containing synthetic complete medium overnight and transferred to 2% raffinose-containing medium, and then HA-E4orf4 expression was induced for 5 h in 2% galactose-plus-2% raffinose-containing medium. Cells were collected and fixed with 4% formaldehyde, and GFP-Cdc55 or Rts1-GFP was visualized by fluorescence microscopy. Image stacks (0.5-μm optical sections with 10 to 12 stacks per image) were acquired using Volocity software. About 150 cells per sample were scored for GFP-Cdc55 and Rts1-GFP localizations. Representative images shown are the extended focus of a z series of 0.5-μm optical sections, and imaging processing was performed with Adobe Photoshop CS. Similar conditions were utilized for the visualization of yellow fluorescent protein (YFP)-Tub1 localization, as depicted in Fig. S2 in the supplemental material, except for the growth conditions under which S-phase synchronization was used (described above).

RESULTS

E4orf4 interacts with Cdc55 but not Rts1.E4orf4 has been shown to interact with the B55/Cdc55 regulatory subunits of PP2A in human cells (1, 20, 22, 37, 38) and yeast (1, 17, 32). Additionally, in yeast, E4orf4 does not associate with the A and C subunits in the absence of Cdc55, suggesting that the E4orf4-PP2A interaction is through Cdc55 alone (32). To define the specificity of the E4orf4-Cdc55 interaction further, we examined whether or not E4orf4 also interacts with Rts1 through coimmunoprecipitation experiments. Yeast cells expressing HA3-Cdc55 or Rts1-HA3 (9) were transformed with either vector control plasmid DNA alone or a plasmid DNA expressing an N-terminal FLAG-tagged E4orf4 protein under the control of the inducible GAL1 promoter. Protein extracts were prepared from cells induced with galactose for 6 h, and epitope-tagged proteins were immunoprecipitated using anti-HA or anti-FLAG antibodies. Copurifying proteins were detected by immunoblotting. Figure 1A shows that, as previously described (32), FLAG-E4orf4 and HA3-Cdc55 were found to interact in reciprocal coimmunoprecipitation experiments. In contrast, Rts1-HA3 and FLAG-E4orf4 did not interact, even though both could be detected independently in the control immunoprecipitations as well as WCEs.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Involvement of Cdc55 and Rts1 in E4orf4 binding and cell killing. (A) Binding to E4orf4. Yeast strains containing endogenously tagged HA3-Cdc55 (MSG36) or Rts1-HA3 (YS69) were transformed with plasmid DNAs encoding a vector control or FLAG-E4orf4. Cell lysates were immunoprecipitated (IP) with anti-HA or anti-FLAG antibodies and subjected to SDS-PAGE and Western blotting with the indicated antibodies. (B) Cell killing. Cultures of W303 wild-type and cdc55Δ, rts1Δ, and cdc55Δ rts1Δ mutant yeast strains containing either vector control DNA or HA-E4orf4 DNA were spotted on noninducing 2% glucose or inducing 2% raffinose-2% galactose agar medium for cell growth assays, as described in Materials and Methods. Photographs were taken after plates were incubated at 30°C for 2 days.

It is widely believed that the cell death function of E4orf4 is mediated primarily through an interaction with the B55/Cdc55 class subunits. To confirm this, cell growth assays were conducted in the presence or absence of E4orf4 using appropriate yeast strains (40). Figure 1B shows that wild-type (WT) cells, cells with deleted Rts1 (rts1Δ mutant), and cells with both Cdc55 and Rts1 deleted (cdc55Δ rts1Δ mutant) were all susceptible to E4orf4-induced toxicity, whereas cells deleted for Cdc55 (cdc55Δ mutant) were significantly more resistant to killing. These results confirm that E4orf4 toxicity, with respect to PP2A, is specific to the Cdc55 subunit. The toxicity in cdc55Δ rts1Δ mutant cells suggests that there is a PP2A-independent perturbation that is uncovered when both targeting subunits are absent. Fig. S1 in the supplemental material shows that cell inviability rather than growth arrest occurred in wild-type E4orf4-expressing cells, as the majority of cells were unable to resume growth at 4 h post-E4orf4 expression, as determined by colony survival assays. These data suggest that misregulation of the PP2ACdc55 pool of PP2A induces cell death and demonstrates that any E4orf4-induced changes in PP2A activity or substrate specificity are solely, or at least predominantly, through Cdc55.

PP2ACdc55 localization is affected by E4orf4.Previous studies with mammalian PP2A complexes suggested that E4orf4 may alter PP2ACdc55 activity (20, 22, 37, 38). We felt that PP2ACdc55 interaction with E4orf4 may also change the localization of PP2ACdc55, thus potentially altering access to critical substrates. During S and M phase, PP2ARts1 localizes to kinetochores and, upon anaphase exit, relocalizes to the bud neck, where it plays a role in septin dynamics and cytokinesis (8, 9). In contrast, PP2ACdc55 trimers (and even Cdc55 monomers) localize via targeting sequences in Cdc55 to bud tips in small or large budded cells and to the bud neck in large budded cells (9). Cdc55 and Rts1 are also found in the cytoplasm and nucleus in all cell cycle phases (9). To determine if E4orf4 binding affects the localization of PP2ACdc55 complexes, control DNA or HA-E4orf4 was expressed in yeast strains expressing GFP-Cdc55 or Rts1-GFP and Spc42-CFP fusion proteins (9). Spc42 is a major component of the spindle pole body (SPB). The SPB duplicates at the G1/S transition, and at that time, the SPBs are in close proximity to kinetochores, prior to SPB separation (10, 16). We previously demonstrated that Rts1-GFP colocalizes with Spc42 during that time (9). Cells were visualized by fluorescence microscopy to determine the localization of GFP-Cdc55 or Rts1-GFP after 6 h of E4orf4 expression (n = 150 cells). Figure 2A (top) shows that in cells containing the control DNA, Rts1-GFP colocalized with Spc42-CFP at the kinetochores, as has previously been reported (9), but we did not consistently observe Rts1-GFP at the bud neck, most probably due to the transient, dynamic nature of this localization. Figure 2A (bottom) shows that in E4orf4-expressing cells Rts1-GFP localized in a fashion similar to that of the kinetochore. Figure 2B shows that in vector control cells, GFP-Cdc55 localized to the bud tip in small (39%) and large (4%) budded cells, to the bud neck in large (59%) budded cells, and to the nucleus in all cell types, as observed previously (9). In contrast, Fig. 2B shows that in E4orf4-expressing cells, GFP-Cdc55 localization was greatly reduced at the bud tip (10% in small and 0% in large budded cells) and bud neck (5%), with clear accumulation in the nucleus in all cell types. The localization data of GFP-Cdc55 in the presence and absence of E4orf4 has been summarized at the bottom of Fig. 2B. Expression of E4orf4 did not disturb the localization of PP2ARts1 but dramatically altered the normal localization of PP2ACdc55 at the bud tip and bud neck.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Effect of E4orf4 on the localization of Rts1 and Cdc55. (A) Rts1. Cells expressing Rts1-GFP (shown in green) and Spc42-CFP (shown in red) fusion proteins (MSG136) were transformed with control plasmid DNA or DNA expressing HA-E4orf4. Cells were prepared and visualized by fluorescence microscopy as detailed in Materials and Methods. The images shown are representative of Rts1-GFP kinetochore and Spc42-CFP spindle pole body localizations. The merged image shows that Rts1-GFP colocalizes near Spc42-CFP. (B) Cdc55. Control vector DNA or DNA expressing HA-E4orf4 was expressed in a strain that expresses GFP-CDC55 (MSG107). Shown are representative GFP-Cdc55 localizations in the nucleus and bud tip (left) and at the bud neck (middle). Shown on the right is the most common pattern exhibited when E4orf4 is expressed, GFP-Cdc55 being concentrated in the nucleus in the great majority of cells. The table at the bottom shows the percentage of unbudded, small budded, and large budded cells with GFP-Cdc55 at the indicated locations in the absence or presence of E4orf4. N/A, not applicable.

E4orf4 expression induces accumulation of G2/M-phase cells and elevated Clb2-Cdc28/Cdk1 activity.Previous studies suggested that E4orf4 induces mitotic arrest in both yeast (1, 17, 32) and mammalian (20, 21) cells. To examine this effect more thoroughly, vector control yeast cells or those expressing E4orf4 were grown asynchronously in noninducing glucose medium and then in raffinose medium, before being transferred to inducing galactose-containing medium for 6 h and then analyzed by FACS. Figure 3A shows that, at both 3 and 6 h post-galactose induction, wild-type cells expressing E4orf4 contained a greater population of 2N cells than controls, suggesting that E4orf4 induces an accumulation of G2/M cells. In the case of cdc55Δ mutant cells, expression of E4orf4 yielded cell cycle profiles similar to those of the vector control, suggesting that the observed effects on the cell cycle by E4orf4 were PP2ACdc55 dependent. Figure 3B shows the results of a study using the same cultures described in the legend for Fig. 3A, from which immunoprecipitates prepared using antibodies against Clb2 were tested in vitro for Cdk1 activity using [γ32P]ATP and histone H1 as the substrate, as described in Materials and Methods. Whereas wild-type cells expressing E4orf4 exhibited levels of Cdk1 activity significantly higher than those of the vector control, the activity in cdc55Δ mutant cells was similar to that of the control, regardless of the presence or absence of E4orf4. Thus, the accumulation of G2/M cells, in parallel with high mitotic kinase activity, suggests that E4orf4 expression perturbs cell cycle timing and regulation of Clb2-Cdc28/Cdk1 activity by a mechanism that is dependent on PP2ACdc55.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Effect of E4orf4 on the cell cycle and Clb2-Cdc28/Cdk1 activity. (A) Analysis of cell cycle. Wild-type or cdc55Δ mutant cells transformed with either control plasmid DNA or that expressing E4orf4 were grown asynchronously, and cells harvested at 3 and 6 h postinduction in preparation for FACS analysis, as indicated and described in Materials and Methods. (B) Measurement of Cdk1 activity. WCEs from asynchronous wild-type or cdc55Δ mutant cells transformed with either control plasmid DNA or that expressing E4orf4 were grown for 6 h, and then extracts were immunoprecipitated using antibodies against Clb2. In vitro kinase assays were then performed using [γ32P]ATP and histone H1 as substrate, as described in Materials and Methods. The figure shows an autoradiograph of analysis by SDS-PAGE of equal aliquots of the kinase assays.

Clb2 overexpression induces high Cdk1 kinase activity and cell death.The lethality associated with E4orf4 expression in yeast cells could arise from high levels of Clb2-associated Cdk1 activity that we observed with E4orf4-expressing cells (32). To test the hypothesis that uncontrolled activation of Clb2-Cdc28/Cdk1 kinase is toxic, we assayed the viability of cells overproducing Clb2. Cells were transformed with DNA expressing galactose-inducible HA-tagged Clb2 or control vector DNA. After galactose induction, cells were collected, extracts were immunoprecipitated using anti-Clb2 antibodies, and the precipitates were tested for Clb2-Cdc28/Cdk1 kinase activity, as shown in Fig. 3B. Figure 4A (top) indicates the levels of Clb2 detected by immunoblotting using anti-Clb2 antibodies, and Fig. 4A (bottom) shows that Cdk1 kinase activity was greatly increased in cells that overexpressed Clb2 compared to the vector control. To determine the effect of increased Clb2 expression and Cdk1 activity on cell viability, spotting assays were also performed, as shown in Fig. 1B. Figure 4B shows that overexpression of Clb2 severely reduced cell viability. These results demonstrate that the unregulated activity of Clb2-Cdc28/Cdk1 is indeed toxic to cells. This opens the possibility that the Cdc55-dependent toxicity of E4orf4 at least in part arises from high levels of Clb2-Cdk1 activity.

FIG. 4.
  • Open in new tab
  • Download powerpoint
FIG. 4.

Effect of overexpression of Clb2. Cells were transformed with control plasmid DNA or that expressing Clb2-HA3 under the GAL1 promoter and then cultured in galactose-containing medium to induce Clb2 expression. (A) Clb2 expression and Cdk1 activity. Top, Western blotting using anti-Clb2 antibodies. Bottom, WCEs were subjected to immunoprecipitation with anti-Clb2 antibodies followed by Cdk1 kinase assays, as described in the legend for Fig. 3B. (B) Cell viability. Cells were grown in liquid medium and then spotted on 2% glucose-containing agar plates (noninducing) or 2% galactose-2% raffinose plates (inducing). Photographs were taken after plates were incubated at 30°C for 2 days.

E4orf4 expression correlates with reduced levels of substrates downstream of APCCdc20 in S-phase cells.The observed increase in Clb2-Cdc28/Cdk1 activity due to E4orf4 expression led us to investigate whether inappropriate Cdk1 activation could be decoupling the timing of mitotic progression. This seemed plausible, as phosphorylation of the core APC subunits by Clb2-Cdc28/Cdk1 is known to be required for association of the APC with its cofactor Cdc20, leading to activation of APCCdc20 (18, 33). Another possibility could be that E4orf4 expression led to a mitotic arrest, which is consistent with the observation of an accumulation of cells in G2/M that could have resulted from the high Clb2-Cdc28/Cdk1 activity. To determine whether the former was indeed the case, we tested the capability of E4orf4 to induce APCCdc20 activation in cells arrested in S phase by HU. We accomplished this by examining the levels of substrates downstream of APCCdc20 and DNA content, with respect to E4orf4 expression.

E4orf4 expression reduces levels of Pds1/securin in S-phase cells.Pds1/securin is an APCCdc20 substrate that is rapidly degraded when APCCdc20 is activated. It is well established that degradation of ubiquitinated Pds1 by APCCdc20 is required for dissolution of the cohesin complex and sister chromatid segregation at anaphase (4, 5, 41, 42). During S phase, Pds1 is normally stable and blocks the activity of Esp1, which cleaves Scc1. We reasoned that if E4orf4 expression results in unregulated Cdc28-Clb2/Cdk1 activity, premature APCCdc20 activation might occur. We tested this using a strain which contained endogenously expressed functional Myc-tagged Pds1 fusion protein (Pds1-Myc18) (4). Cells transformed with either vector control plasmid DNA or DNA expressing FLAG-E4orf4 were blocked in S phase with 0.2 M HU under noninducing conditions (T = 0 h). After half of the culture was collected for analysis, cells were grown under inducing conditions in 0.2 M HU for 3 h (T = 3 h) to induce E4orf4 expression while maintaining the S-phase arrest. Pds1-Myc18 levels in WCEs were determined by Western blotting using anti-Myc antibody and those of E4orf4 using anti-FLAG antibody. FLAG-E4orf4 protein could be detected after 2 h of induction and was maximal by 3 h (data not shown). Figure 5A shows that after 3 h of induction to allow for E4orf4 expression, Pds1-Myc18 in WCEs was reduced compared to that in vector control WCEs, with equal amounts of protein loaded, as demonstrated by Cdc28 levels using anti-Cdc28 antibodies. Figure 5B shows the results of FACS analysis of these cultures, indicating that the majority of cells incubated in the presence of HU were present in a single major fraction typical of S-phase cells, whereas untreated cultures exhibited a biphasic pattern characteristic of asynchronously growing cells. Thus, these results suggest that E4orf4 expression reduces Pds1 levels in S-phase-arrested cells.

FIG. 5.
  • Open in new tab
  • Download powerpoint
FIG. 5.

E4orf4 promotes premature proteolysis of Pds1 (securin) in cells arrested in S phase by HU. Yeast cells containing endogenous Myc-tagged PDS1 (strain 6803) were transformed with either control plasmid DNA or that expressing E4orf4. Cells were synchronized in S phase with 0.2 M HU for 5 h (T = 0 h), after which E4orf4 expression was induced in the continued presence of HU for another 3 h (T = 3 h), as described in Materials and Methods. (A) Analysis by Western blotting. Equal aliquots of cell extracts were subjected to Western blotting using antibodies against Myc (top), FLAG (middle), or Cdc28 (bottom). (B) FACS analysis. Cells from the same samples described in the legend for panel A were analyzed by FACS, as described in Materials and Methods.

E4orf4 expression reduces levels of Scc1/cohesin in S-phase cells.Normally, Pds1 binds to Esp1 and inhibits its protease activity against the cohesin subunit Scc1 (4, 5). After Pds1 is ubiquitinated by APCCdc20 and degraded by the proteasome, Esp1 becomes free to cleave Scc1, thus promoting the dissolution of the cohesin complex and sister chromatid separation (42). To study the effect of E4orf4 on the stability of Scc1-Myc18 (25), vector control and E4orf4-expressing cells were again examined according to the same protocol of HU treatment as that described in the legend for Fig. 5. Figure 6A shows that Scc1-Myc18 levels significantly decreased by 4 h of E4orf4 expression, whereas they remained high in control cells. Equal amounts of protein, as demonstrated by Cdc28 levels, were loaded. Figure 6B shows that by FACS, HU retained the majority of cells in S phase, and Fig. 6C indicates that E4orf4 expression resulted in elevated Clb2-Cdc28/Cdk1 activity. It should be noted that upon repeated analyses, the observed increase in Cdk1 activity was often more modest than that of the experiment shown; however, this difference could be due to the presence of considerably lower levels of Clb2 during S phase. Nonetheless, these results suggested that the observed premature decrease in Pds1 levels in E4orf4-expressing cells appeared to promote the premature release of Esp1, thus resulting in the inappropriate loss of Scc1.

FIG. 6.
  • Open in new tab
  • Download powerpoint
FIG. 6.

E4orf4 promotes premature proteolysis of Scc1 (cohesin) in cells arrested in S phase by HU. An experiment similar to that described in the legend for Fig. 5 was conducted, except the fate of Scc1 (cohesin) was examined with yeast containing endogenous Myc-tagged SCC1 (strain 6565). (A) Analysis by Western blotting. (B) FACS. (C) Cdk1 assays. Whole-cell extracts were immunoprecipitated with anti-Clb2 antibody, and equal aliquots were assayed for Cdk1 kinase activity, as described in the legends for Fig. 3B and 4A.

E4orf4 expression does not cause bypass of S-phase checkpoints.We observed that expression of E4orf4 in S-phase-arrested cells appears to reduce levels of Pds1 and Scc1, both of which are degraded as a consequence of the activation of APCCdc20. This is consistent with E4orf4 expression inducing premature activation of APCCdc20. However, if E4orf4 expression causes HU-treated cells to bypass S-phase (DNA damage/replication) checkpoints, Pds1 levels would decrease as a consequence of entry into anaphase. To determine if this was the case, the morphology of spindles labeled with YFP-tubulin was examined in HU-arrested cells after 4 h of E4orf4 induction (see Fig. S2 in the supplemental material). Indeed, HU-arrested cells expressing E4orf4 contained either monopolar or short bipolar spindles located in the mother cell, consistent with an S-phase arrest. This analysis verified that E4orf4 and concomitant uncoupling of Clb2-Cdc28/Cdk1 activity did not allow cells to enter anaphase. Importantly, these results suggest that the E4orf4-dependent reduction of Pds1 and Scc1 in HU-treated cells is due to premature activation of APCCdc20.

E4orf4 expression does not reduce Cdc5 and Cdc20 levels in S-phase cells.Considering that E4orf4 expression appeared to reduce Pds1 and Scc1 levels, studies were conducted to determine if the substrates of the second form of APC, APCHct1, were also affected, by examining the levels of two of its substrates, Cdc5 and Cdc20 (2, 11, 28, 35). Yeast strains expressing Cdc5-Myc15 or Cdc20-Myc18 (35, 50) were transformed with either control vector DNA or DNA expressing HA-E4orf4, and experiments with HU-treated cells were conducted as described in the legends for Fig. 5 and 6. Figure 7A shows that after 4 h of E4orf4 expression in the presence of HU, Cdc5-Myc15 levels were similar to those in control cells. Figure 7B shows that similar results were also observed with Cdc20-Myc18, a component of the first APCCdc20 and a substrate of APCHct1. Again, equal amounts of protein, as demonstrated by Cdc28 levels, were loaded. These results suggested that unlike substrates downstream of APCCdc20, those of APCHct1, specifically Cdc5 and Cdc20, were not prematurely degraded when E4orf4 was expressed in HU-treated cells.

FIG. 7.
  • Open in new tab
  • Download powerpoint
FIG. 7.

E4orf4 does not induce degradation of APCHct1 substrates Cdc5 and Cdc20 in cells arrested in S phase by HU. Experiments similar to those described in the legends for Fig. 5 and 6 were conducted, except the fates of Cdc5 and Cdc20 were examined with HU-treated cells. The levels of Cdc5 (strain 6142) and Cdc20 (strain 425) were determined by Western blotting using antibodies against Myc. (A) Myc-tagged Cdc5; (B) Myc-tagged Cdc20.

Reduction of Pds1 and Scc1 by E4orf4 in S-phase cells is PP2ACdc55 dependent.We have shown previously that much of the toxicity of E4orf4 in yeast requires a functional interaction with the Cdc55 subunit of PP2A, as mutations in E4orf4 that block this interaction also reduce toxicity (32). To establish further the role of PP2ACdc55 in the E4orf4-induced reduction of Pds1 and Scc1, studies of HU similar to those described in the legend for Fig. 5 to 7 were performed using two types of E4orf4 mutants. The class I E4orf4 mutant R81AF84A fails to bind B55/Cdc55 and is not toxic in either yeast or mammalian cells (22, 32). The class II mutant K88A is capable of binding B55/Cdc55, but this interaction is believed to be nonfunctional, as it fails to induce significant toxicity. Figure 8A shows that Pds1-Myc18 levels were again decreased following expression of wild-type E4orf4, while with both the R81AF84A and K88A mutants, Pds1-Myc18 appeared to be present at levels similar to those in control cells. We performed similar experiments to probe the levels of Scc1 in the presence of mutant E4orf4. Figure 8C shows that the same outcome was evident with Scc1-Myc18. Equal amounts of protein, as demonstrated by Cdc28 levels, were loaded. These results predict that mutation of E4orf4 should result in increased cell viability. Figure 8B and D show growth assays confirming that these mutants do in fact increase cell viability. These results suggest that the reduction of both Pds1 and Scc1 by E4orf4 is dependent on its functional interaction with Cdc55.

FIG. 8.
  • Open in new tab
  • Download powerpoint
FIG. 8.

Degradation of Pds1 and Scc1 in cells arrested in S phase by HU is dependent on a functional interaction between E4orf4 and Cdc55. An experiment similar to those described in the legends for Fig. 5 and 6 were performed, but, in addition to cells transformed with control vector DNA or DNA expressing FLAG-tagged wild-type E4orf4 (Fig. 7A to D), mutant E4orf4 protein R81AF84A or K88A was also expressed in 6803 (Myc-tagged Pds1, Fig. 7A and B) or 6565 (Myc-tagged Scc1, Fig. 7C and D) cells. The stability of Pds1 and Scc1 was examined as described in the legends for Fig. 5 and 6, and the viability of these cells was determined as described in the legend for Fig. 4B. (A) Pds1 stability; (B) Pds1 cell viability; (C) Scc1 stability; (D) Scc1 cell viability.

DISCUSSION

We have demonstrated in this study that E4orf4 in yeast functions via the Cdc55-specific form of PP2A to uncouple the timing of Clb2-Cdc28/Cdk1 activity, resulting in the S-phase reduction of levels of Pds1, normally a substrate APCCdc20 in anaphase, and of Scc1, whose stability depends on the presence of Pds1. These results are summarized in Fig. 9. We believe that the inappropriate reduction of these critical mitotic proteins prior to anaphase by E4orf4 at least partially explains the mechanism by which E4orf4 causes growth defects, ultimately leading to cell death in yeast.

FIG. 9.
  • Open in new tab
  • Download powerpoint
FIG. 9.

Model for activation of Clb2-Cdc28/Cdk1 and APCCdc20 by E4orf4. This figure illustrates the steps involved in APC activation, degradation of APC substrates, and the potential role of E4orf4 and PP2ACdc55 in this process. E4orf4 induces Cdk1 activity, and PP2A is believed to positively regulate the stability of Swe1 and may negatively regulate formation of APCCdc20 via dephosphorylation of core proteins. Cdk1 is known to promote the activation of APCCdc20 and to inhibit activation of APCHct1. Our results suggest that activation of Cdk1 by E4orf4 expression could occur, at least in part, from the inhibition of PP2ACdc55 that could affect Swe1 or other factors that regulate Cdk1 activity. Inhibition of PP2ACdc55 could also promote activation of APCCdc20. P, phosphorylated.

The effects of E4orf4 expression are exerted principally through the Cdc55 regulatory subunit of PP2A, as demonstrated by the specific functional binding between these two proteins and the distinct localization change of PP2ACdc55 in the presence of E4orf4. As Cdc55 controls the intracellular localization of PP2ACdc55 (9), the observed localization of PP2ACdc55 primarily to the nucleus raises the possibility that E4orf4 redirects PP2A activity toward inappropriate substrates and/or prevents normal PP2A activity against bona fide substrates. Our work with mammalian cells indicated that binding of E4orf4 to the B55/Bα subunit inhibits the formation of active Bα-containing PP2A holoenzymes (20). It is unknown whether or not the inhibited holoenzyme is inactive against all substrates or if novel phosphoproteins become inappropriate targets. Our hypothesis is that the binding of the E4orf4 protein to B55 subunits in mammalian cells blocks the access of at least some substrates to the substrate binding site shared by the PP2A B and C subunits and that this inhibition causes both mitotic arrest and cell killing by E4orf4 (20). Although we have not measured directly the effects of E4orf4 on yeast Cdc55-specific phosphatase activity, because of the high degree of similarity of structure and function with mammalian PP2A (12), we suspect that a similar inhibition may also occur with yeast Cdc55-containing PP2A holoenzymes.

Previous studies had suggested that E4orf4 affects mitotic processes (17, 20, 21, 32), and indeed, these ideas are consistent with the results of the present study. E4orf4 was found to increase Clb2-Cdc28/Cdk1 activity in a manner dependent on its functional interaction with Cdc55. Our studies examining the relative abundance of APC substrates (Pds1, Cdc20, and Cdc5) following expression of wild-type or mutant forms of E4orf4 in HU-treated S-phase cells suggested that the toxicity of E4orf4 results from the premature activation of APCCdc20 and the failure to activate APCHct1. Comparable results have also been obtained when unsynchronized growing cells were examined (data not shown).

A previous study proposed that APC activity is reduced as a consequence of E4orf4 expression (17). Those authors suggested that the E4orf4-induced inhibition of APCs, in combination with high Clb2-Cdc28/Cdk1 activity, created conflicting signals in the cell that result in death. This hypothesis is in apparent conflict with our present results, which suggest the APCCdc20 is inappropriately active in S-phase E4orf4-expressing yeast cells, resulting in reduced levels of Pds1 as well as the Esp1 substrate Scc1. It is important to note that the previous study did not examine the impact of E4orf4 on S-phase levels of proteins whose stability is controlled by the APC. Thus, an explanation for the observed difference between our study and that of Kornitzer et al. (17) is that the impact of E4orf4 on PP2A targeting and activity during S phase may be mechanistically distinct from that in mitosis.

In this study, we show that E4orf4 expression results in an increase in Clb2-Cdc28/Cdk1 activity in S-phase cells. As Cdk1 is known to phosphorylate APC subunits and contribute to APCCdc20 activity, it seems reasonable to conclude that the premature activation of APCCdc20 seen with E4orf4-expressing cells resulted from the PP2ACdc55-dependent increase in Clb2-Cdc28/Cdk1 activity. Thus, one aspect of the toxicity of E4orf4 is that its activity against PP2A uncouples Cdc28 and APC activity from the cell cycle state. This idea is validated by the observation that overexpression of Clb2 was lethal. This proof-of-principle experiment supported the hypothesis that the increased Clb2-Cdc28/Cdk1 activity induced by E4orf4 expression may be a critical step in the mechanism leading to cell death. It is important to consider that our cell viability experiments are based on the analysis of cells that may be perturbed in both S phase and M phase, and the additive effect on these two cell cycle states leads to a cell cycle delay that ultimately fails, returning defective cells to the cell cycle and resulting in death.

The altered localization of PP2ACdc55 primarily to the nucleus in E4orf4-expressing cells leads to the possibility of enhanced PP2ACdc55 activity directed toward nuclear substrates and reduced activity toward cytoplasmic substrates. How this spatially restricted PP2ACdc55 activity affects the regulation of Cdc28, either directly or indirectly, in S-phase cells is still unknown. Our present study would favor a model in which PP2ACdc55 is a negative regulator of Clb2-Cdk1 in S phase, possibly invoking the activation of Swe1 and inactivation of Mih1 in the nucleus. Figure 9 summarizes our current model for the possible involvement of E4orf4 in mediating the activation of Clb2-Cdc28/Cdk1. Studies are under way to examine more thoroughly the effects of E4orf4 expression on specific factors that regulate Cdk1 activity.

While APCCdc20 appeared to be prematurely activated in the presence of E4orf4, APCHct1 was not, as suggested by the stability of its substrates Cdc20 and Cdc5. At present, we are still uncertain if expression of E4orf4, which results in elevated levels of Clb2-Cdc28/Cdk1, prevents the formation of APCHct1 through inhibitory phosphorylation or if the activity of this complex itself is inhibited. The simplest hypothesis would be that high levels of Cdk1 maintain Hct1 in a highly phosphorylated state, thus making it incapable of forming a complex with the APC core proteins. Studies are currently under way to examine this question.

E4orf4 induces cell death through PP2ACdc55, as cell viability is mostly rescued in cdc55Δ mutant strains (17, 32). This line of evidence is again confirmed in this study. However, with the observation that toxicity is never fully relieved in cdc55Δ mutant cells expressing E4orf4 (Fig. 1B), we recognize the potential existence of secondary E4orf4 targets that may decrease viability in a manner independent of the Cdc55 pathway. Such a possibility is evident in the decreased viability of cdc55Δ rts1Δ mutant cells expressing E4orf4 (Fig. 1B). Without the presence of regulatory subunits, E4orf4 likely can no longer transduce its effects through PP2A and may be doing so through other phosphatases of the same class. This seems plausible, as considerable functional redundancy exists between phosphatases in yeast (34). Thus, the E4orf4-induced toxicity observed with cdc55Δ rts1Δ mutant cells may result from off-target effects. Nevertheless, we believe that in cells expressing PP2A, E4orf4 mediates its toxic effects mostly through the pool of PP2ACdc55. This contention is demonstrated in Fig. 1B, in which E4orf4 is shown to be even more lethal in rts1Δ mutant cells. In such a situation, cells presumably contain only the PP2ACdc55 form, thus making Cdc55 the predominant pathway by which E4orf4 induces cell death.

In this present study, we have found that E4orf4 uncouples PP2ACdc55 regulation of mitotic events, leading to unscheduled degradation of specific APC substrates and a defect in mitotic exit. The role that PP2A plays within mitosis has been well studied over the past few years; however, much is still unknown. Equally unknown is the identity of PP2A substrates. As E4orf4 is believed to be a specific inhibitor of PP2ACdc55, it may serve as a unique and powerful tool for identifying the cellular processes and pathways regulated by PP2ACdc55.

ACKNOWLEDGMENTS

We thank W. Zachariae, K. Nasmyth, B. J. Andrews, and R. J. Deshaies for generously supplying reagents and Ken McDonald for technical assistance with the FACScan. We also thank members of the Branton and Vogel labs for helpful discussions.

This work was supported by grants from the Canadian Cancer Society (P.E.B.), the Canadian Institutes of Health Research (CIHR) (P.E.B. and J.V.), and the Fonds de la Recherche en Santé du Québec (FRSQ) (P.E.B.). M.Z.M. received support from a McGill University Faculty of Medicine Internal Studentship and a Studentship from the CIHR. D.E.R. had a studentship from the FRSQ, and J.V. is supported by a CIHR New Investigator Award.

FOOTNOTES

    • Received 18 November 2009.
    • Accepted 8 February 2010.
  • Copyright © 2010 American Society for Microbiology

REFERENCES

  1. 1.↵
    Branton, P. E., and D. E. Roopchand. 2001. The role of adenovirus E4orf4 protein in viral replication and cell killing. Oncogene20:7855-7865.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Charles, J. F., S. L. Jaspersen, R. L. Tinker-Kulberg, L. Hwang, A. Szidon, and D. O. Morgan. 1998. The Polo-related kinase Cdc5 activates and is destroyed by the mitotic cyclin destruction machinery in S. cerevisiae. Curr. Biol.8:497-507.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Chen, D. C., B. C. Yang, and T. T. Kuo. 1992. One-step transformation of yeast in stationary phase. Curr. Genet.21:83-84.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    Ciosk, R., W. Zachariae, C. Michaelis, A. Shevchenko, M. Mann, and K. Nasmyth. 1998. An ESP1/PDS1 complex regulates loss of sister chromatid cohesion at the metaphase to anaphase transition in yeast. Cell93:1067-1076.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Cohen-Fix, O., J. M. Peters, M. W. Kirschner, and D. Koshland. 1996. Anaphase initiation in Saccharomyces cerevisiae is controlled by the APC-dependent degradation of the anaphase inhibitor Pds1p. Genes Dev.10:3081-3093.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    D'Amours, D., and A. Amon. 2004. At the interface between signaling and executing anaphase—Cdc14 and the FEAR network. Genes Dev.18:2581-2595.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Dien, B. S., M. S. Peterson, and F. Srienc. 1994. Cell cycle analysis of Saccharomyces cerevisiae. Methods Cell Biol.42:457-475.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    Dobbelaere, J., M. S. Gentry, R. L. Hallberg, and Y. Barral. 2003. Phosphorylation-dependent regulation of septin dynamics during the cell cycle. Dev. Cell4:345-357.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    Gentry, M. S., and R. L. Hallberg. 2002. Localization of Saccharomyces cerevisiae protein phosphatase 2A subunits throughout mitotic cell cycle. Mol. Biol. Cell13:3477-3492.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Goh, P. Y., and J. V. Kilmartin. 1993. NDC10: a gene involved in chromosome segregation in Saccharomyces cerevisiae. J. Cell Biol.121:503-512.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    Huang, J. N., I. Park, E. Ellingson, L. E. Littlepage, and D. Pellman. 2001. Activity of the APC(Cdh1) form of the anaphase-promoting complex persists until S phase and prevents the premature expression of Cdc20p. J. Cell Biol.154:85-94.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J.353:417-439.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Janssens, V., S. Longin, and J. Goris. 2008. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem. Sci.33:113-121.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    Jaspersen, S. L., J. F. Charles, and D. O. Morgan. 1999. Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr. Biol.9:227-236.
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    Jiang, Y. 2006. Regulation of the cell cycle by protein phosphatase 2A in Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev.70:440-449.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    Jin, Q., E. Trelles-Sticken, H. Scherthan, and J. Loidl. 1998. Yeast nuclei display prominent centromere clustering that is reduced in nondividing cells and in meiotic prophase. J. Cell Biol.141:21-29.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    Kornitzer, D., R. Sharf, and T. Kleinberger. 2001. Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex/cyclosome. J. Cell Biol.154:331-344.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    Kraft, C., F. Herzog, C. Gieffers, K. Mechtler, A. Hagting, J. Pines, and J. M. Peters. 2003. Mitotic regulation of the human anaphase-promoting complex by phosphorylation. EMBO J.22:6598-6609.
    OpenUrlAbstract
  19. 19.↵
    Lavoie, J. N., M. Nguyen, R. C. Marcellus, P. E. Branton, and G. C. Shore. 1998. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol.140:637-645.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    Li, S., C. Brignole, R. Marcellus, S. Thirlwell, O. Binda, M. J. McQuoid, D. Ashby, H. Chan, Z. Zhang, M. J. Miron, D. C. Pallas, and P. E. Branton. 2009. The adenovirus E4orf4 protein induces G2/M arrest and cell death by blocking protein phosphatase 2A activity regulated by the B55 subunit. J. Virol.83:8340-8352.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    Li, S., A. Szymborski, M. J. Miron, R. Marcellus, O. Binda, J. N. Lavoie, and P. E. Branton. 2009. The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells. Oncogene28:390-400.
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    Marcellus, R. C., H. Chan, D. Paquette, S. Thirwell, D. Boivin, and P. E. Branton. 2000. Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Ba subunit of protein phosphatase 2A. J. Virol.74:7869-7877.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Marcellus, R. C., J. N. Lavoie, D. Boivin, G. C. Shore, G. Ketner, and P. E. Branton. 1998. The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis. J. Virol.72:7144-7153.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Mendenhall, M. D., and A. E. Hodge. 1998. Regulation of Cdc28 cyclin-dependent protein kinase activity during the cell cycle of the yeast Saccharomyces cerevisiae. Microbiol. Mol. Biol. Rev.62:1191-1243.
    OpenUrlAbstract/FREE Full Text
  25. 25.↵
    Michaelis, C., R. Ciosk, and K. Nasmyth. 1997. Cohesins: chromosomal proteins that prevent premature separation of sister chromatids. Cell91:35-45.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Millward, T. A., S. Zolnierowicz, and B. A. Hemmings. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci.24:186-191.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Miron, M. J., I. E. Gallouzi, J. N. Lavoie, and P. E. Branton. 2004. Nuclear localization of the adenovirus E4orf4 protein is mediated through an arginine-rich motif and correlates with cell death. Oncogene23:7458-7468.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Morgan, D. O. 1999. Regulation of the APC and the exit from mitosis. Nat. Cell Biol.1:E47-E53.
    OpenUrlCrossRefPubMedWeb of Science
  29. 29.↵
    Peters, J. M. 2006. The anaphase promoting complex/cyclosome: a machine designed to destroy. Nat. Rev. Mol. Cell Biol.7:644-656.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    Queralt, E., C. Lehane, B. Novak, and F. Uhlmann. 2006. Downregulation of PP2A(Cdc55) phosphatase by separase initiates mitotic exit in budding yeast. Cell125:719-732.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    Queralt, E., and F. Uhlmann. 2008. Separase cooperates with Zds1 and Zds2 to activate Cdc14 phosphatase in early anaphase. J. Cell Biol.182:873-883.
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    Roopchand, D. E., J. M. Lee, S. Shahinian, D. Paquette, H. Bussey, and P. E. Branton. 2001. Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A. Oncogene20:5279-5290.
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    Rudner, A. D., and A. W. Murray. 2000. Phosphorylation by Cdc28 activates the Cdc20-dependent activity of the anaphase-promoting complex. J. Cell Biol.149:1377-1390.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    Sakumoto, N., I. Matsuoka, Y. Mukai, N. Ogawa, Y. Kaneko, and S. Harashima. 2002. A series of double disruptants for protein phosphatase genes in Saccharomyces cerevisiae and their phenotypic analysis. Yeast19:587-599.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    Shirayama, M., W. Zachariae, R. Ciosk, and K. Nasmyth. 1998. The Polo-like kinase Cdc5p and the WD-repeat protein Cdc20p/fizzy are regulators and substrates of the anaphase promoting complex in Saccharomyces cerevisiae. EMBO J.17:1336-1349.
    OpenUrlAbstract
  36. 36.↵
    Shtrichman, R., and T. Kleinberger. 1998. Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells. J. Virol.72:2975-2982.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Shtrichman, R., R. Sharf, H. Barr, T. Dobner, and T. Kleinberger. 1999. Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A. Proc. Natl. Acad. Sci. U. S. A.96:10080-10085.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    Shtrichman, R., R. Sharf, and T. Kleinberger. 2000. Adenovirus E4orf4 protein interacts with both Balpha and B′ subunits of protein phosphatase 2A, but E4orf4-induced apoptosis is mediated only by the interaction with Balpha. Oncogene19:3757-3765.
    OpenUrlCrossRefPubMedWeb of Science
  39. 39.↵
    Shu, Y., and R. L. Hallberg. 1995. SCS1, a multicopy suppressor of hsp60-ts mutant alleles, does not encode a mitochondrially targeted protein. Mol. Cell. Biol.15:5618-5626.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Shu, Y., H. Yang, E. Hallberg, and R. Hallberg. 1997. Molecular genetic analysis of Rts1p, a B′ regulatory subunit of Saccharomyces cerevisiae protein phosphatase 2A. Mol. Cell. Biol.17:3242-3253.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    Uhlmann, F., F. Lottspeich, and K. Nasmyth. 1999. Sister-chromatid separation at anaphase onset is promoted by cleavage of the cohesin subunit Scc1. Nature400:37-42.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    Uhlmann, F., D. Wernic, M. A. Poupart, E. V. Koonin, and K. Nasmyth. 2000. Cleavage of cohesin by the CD clan protease separin triggers anaphase in yeast. Cell103:375-386.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    Virshup, D. M. 2000. Protein phosphatase 2A: a panoply of enzymes. Curr. Opin. Cell Biol.12:180-185.
    OpenUrlCrossRefPubMedWeb of Science
  44. 44.↵
    Visintin, R., S. Prinz, and A. Amon. 1997. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science278:460-463.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    Wang, Y., and D. J. Burke. 1997. Cdc55p, the B-type regulatory subunit of protein phosphatase 2A, has multiple functions in mitosis and is required for the kinetochore/spindle checkpoint in Saccharomyces cerevisiae. Mol. Cell. Biol.17:620-626.
    OpenUrlAbstract/FREE Full Text
  46. 46.
    Wang, Y., and T. Y. Ng. 2006. Phosphatase 2A negatively regulates mitotic exit in Saccharomyces cerevisiae. Mol. Biol. Cell17:80-89.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    Yellman, C. M., and D. J. Burke. 2006. The role of Cdc55 in the spindle checkpoint is through regulation of mitotic exit in Saccharomyces cerevisiae. Mol. Biol. Cell17:658-666.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Yeong, F. M., H. H. Lim, C. G. Padmashree, and U. Surana. 2000. Exit from mitosis in budding yeast: biphasic inactivation of the Cdc28-Clb2 mitotic kinase and the role of Cdc20. Mol. Cell5:501-511.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    Yu, H. 2002. Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin. Cell Biol.14:706-714.
    OpenUrlCrossRefPubMedWeb of Science
  50. 50.↵
    Zachariae, W., M. Schwab, K. Nasmyth, and W. Seufert. 1998. Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science282:1721-1724.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    Zhao, Y., G. Boguslawski, R. S. Zitomer, and A. A. DePaoli-Roach. 1997. Saccharomyces cerevisiae homologs of mammalian B and B′ subunits of protein phosphatase 2A direct the enzyme to distinct cellular functions. J. Biol. Chem.272:8256-8262.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Adenovirus Protein E4orf4 Induces Premature APCCdc20 Activation in Saccharomyces cerevisiae by a Protein Phosphatase 2A-Dependent Mechanism
Melissa Z. Mui, Diana E. Roopchand, Matthew S. Gentry, Richard L. Hallberg, Jackie Vogel, Philip E. Branton
Journal of Virology Apr 2010, 84 (9) 4798-4809; DOI: 10.1128/JVI.02434-09

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Adenovirus Protein E4orf4 Induces Premature APCCdc20 Activation in Saccharomyces cerevisiae by a Protein Phosphatase 2A-Dependent Mechanism
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Adenovirus Protein E4orf4 Induces Premature APCCdc20 Activation in Saccharomyces cerevisiae by a Protein Phosphatase 2A-Dependent Mechanism
Melissa Z. Mui, Diana E. Roopchand, Matthew S. Gentry, Richard L. Hallberg, Jackie Vogel, Philip E. Branton
Journal of Virology Apr 2010, 84 (9) 4798-4809; DOI: 10.1128/JVI.02434-09
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Adenoviruses, Human
Cell Cycle Proteins
Protein Phosphatase 2
Saccharomyces cerevisiae
Saccharomyces cerevisiae Proteins
Ubiquitin-Protein Ligase Complexes
Viral Proteins

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514